JA-Kathy Mngadi - The Aurum Institute

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

Huang, Y., Naidoo, L., Zhang, L., Carpp, L.N., Rudnicki, E., Randhawa, A., Gonzales, P., McDermott, A., Ledgerwood, J., Lorenzo, M.M.G. and Burns, D., 2021. Pharmacokinetics and predicted neutralisati...
Aurum's Kathy Mngadi on Metro FM's The Kings Suite

...
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition

Takuva, S., Karuna, S.T., Juraska, M., Rudnicki, E., Edupuganti, S., Anderson, M., De La Grecca, R., Gaudinski, M.R., Sehurutshi, A., Orrell, C. and Naidoo, L., 2022. Infusion Reactions After Receivi...
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection

Churchyard, G., Cárdenas, V., Chihota, V., Mngadi, K., Sebe, M., Brumskine, W., Martinson, N., Yimer, G., Wang, S.H., Garcia-Basteiro, A.L. and Nguenha, D., 2021. Annual tuberculosis preventive thera...
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Garrett, N., Reddy, T., Yende-Zuma, N., Takalani, A., Woeber, K., Bodenstein, A., Jonas, P., Engelbrecht, I., Jassat, W., Moultrie, H. and Bradshaw, D., 2024. Safety, effectiveness and immunogenicity ...
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.

Gray, G.E., Mngadi, K., Lavreys, L., Nijs, S., Gilbert, P.B., Hural, J., Hyrien, O., Juraska, M., Luedtke, A., Mann, P. and McElrath, M.J., 2024. Mosaic HIV-1 vaccine regimen in southern African women...
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.

Kenny, A., van Duijn, J., Dintwe, O., Heptinstall, J., Burnham, R., Sawant, S., Zhang, L., Mielke, D., Khuzwayo, S., Omar, F.L. and Stanfield-Oakley, S., 2024. Immune correlates analysis of the Imboko...
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Moodie, Z., Andersen-Nissen, E., Grunenberg, N., Dintwe, O.B., Omar, F.L., Kee, J.J., Bekker, L.G., Laher, F., Naicker, N., Jani, I. and Mgodi, N.M., 2024. Safety and immunogenicity of a subtype C ALV...
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

Garrett, N., Tapley, A., Hudson, A., Dadabhai, S., Zhang, B., Mgodi, N.M., Andriesen, J., Takalani, A., Fisher, L.H., Kee, J.J. and Magaret, C.A., 2025. Hybrid versus vaccine immunity of mRNA-1273 amo...

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

Aurum's Kathy Mngadi on Metro FM's The Kings Suite

Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition

Annual Tuberculosis Preventive Therapy for Persons With HIV Infection

Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

Popular Tags

Most Read

Recent Posts